What is BMRA's health score?

BIOMERICA INC (BMRA) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BMRA's estimated fair value?

Based on our 5-year discounted cash flow model, BIOMERICA INC's estimated fair value is $10.72 per share, representing a 349.0% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BMRA undervalued or overvalued?

Our model currently rates BMRA as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BMRA... Refresh in a moment for the full analysis.

BIOMERICA INC (BMRA)

Healthcare Undervalued low weak

$2.39

Updated: 2026-05-30

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

40 Weak

Risk

50 Mixed

Est. Fair Value $10.72

DCF Upside +349.0%

Sector Rank #3360 of 6799

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Altman Z-Score in distress zone — elevated bankruptcy risk

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.